NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	323.77B
Revenue (ttm)	349.19B
Net Income (ttm)	27.12B
Shares Out	17.70M
EPS (ttm)	1,532.00
PE Ratio	11.94
Forward PE	n/a
Dividend	200.00 (1.05%)
Ex-Dividend Date	Dec 27, 2024

Volume	1,204,618
Average Volume	225,670
Open	20,750
Previous Close	20,900
Day's Range	18,290 - 20,750
52-Week Range	6,650 - 22,100
Beta	0.30
RSI	38.90
Earnings Date	Nov 14, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 430
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.